This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

A team of researchers at the University of Pennsylvania took a new approach, using mRNA technology to design a multipronged vaccine that targets several proteins that underlie C. difficile’s ...

Credit: Novikov Aleksey / Shutterstock. US-based pharmaceutical company Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, ...

For currents IM,IT, ICa and ITRPC5 this change is inferred from the qPCR data assuming that the conductance is directly proportional to the mRNA expression." If these were instead based on the ...

aDepartment of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany bDepartment of Pediatric Pulmonology, Allergology, and Neonatology, Hannover Medical School, Hannover 30625 ...